[go: up one dir, main page]

BRPI0920030A2 - agente de oclusão do tecido - Google Patents

agente de oclusão do tecido

Info

Publication number
BRPI0920030A2
BRPI0920030A2 BRPI0920030A BRPI0920030A BRPI0920030A2 BR PI0920030 A2 BRPI0920030 A2 BR PI0920030A2 BR PI0920030 A BRPI0920030 A BR PI0920030A BR PI0920030 A BRPI0920030 A BR PI0920030A BR PI0920030 A2 BRPI0920030 A2 BR PI0920030A2
Authority
BR
Brazil
Prior art keywords
occlusion agent
tissue occlusion
tissue
agent
occlusion
Prior art date
Application number
BRPI0920030A
Other languages
English (en)
Inventor
Kentaro Takamura
Satoru Kobayashi
Satoshi Gojo
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42100586&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0920030(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of BRPI0920030A2 publication Critical patent/BRPI0920030A2/pt
Publication of BRPI0920030B1 publication Critical patent/BRPI0920030B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0920030-4A 2008-10-06 2009-10-06 Agente de oclusão do tecido, agentes hemostáticos, preventivos e de oclusão ou escleroterapia relacionados, e infusão do tecido mucosal BRPI0920030B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2008259860 2008-10-06
JP2008-259860 2008-10-06
JP2008316133 2008-12-11
JP2008-316133 2008-12-11
PCT/JP2009/067367 WO2010041636A1 (ja) 2008-10-06 2009-10-06 組織閉塞剤

Publications (2)

Publication Number Publication Date
BRPI0920030A2 true BRPI0920030A2 (pt) 2015-12-15
BRPI0920030B1 BRPI0920030B1 (pt) 2019-03-26

Family

ID=42100586

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920030-4A BRPI0920030B1 (pt) 2008-10-06 2009-10-06 Agente de oclusão do tecido, agentes hemostáticos, preventivos e de oclusão ou escleroterapia relacionados, e infusão do tecido mucosal

Country Status (13)

Country Link
US (5) US10576123B2 (pt)
EP (5) EP3470093B1 (pt)
JP (4) JPWO2010041636A1 (pt)
KR (1) KR101670099B1 (pt)
CN (2) CN102170919A (pt)
BR (1) BRPI0920030B1 (pt)
ES (3) ES2624484T3 (pt)
HK (1) HK1223025A1 (pt)
PH (2) PH12017501278A1 (pt)
PL (1) PL3470093T3 (pt)
RU (2) RU2011118341A (pt)
SG (1) SG194405A1 (pt)
WO (1) WO2010041636A1 (pt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
CN102170919A (zh) 2008-10-06 2011-08-31 三维肽胶株式会社 组织闭塞剂
ES2653667T3 (es) * 2011-09-02 2018-02-08 3-D Matrix, Ltd. Péptidos anfifílicos para la oclusión del escape de aire torácico
US11260072B2 (en) 2011-09-07 2022-03-01 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
US10905708B2 (en) 2011-09-07 2021-02-02 3-D Matrix, Ltd. MicroRNA-based methods and assays for osteocarcinoma
CN102408575B (zh) * 2011-09-09 2013-02-13 南京大学 一种可注射多肽水凝胶的制备方法
WO2013133413A1 (ja) 2012-03-09 2013-09-12 株式会社スリー・ディー・マトリックス 粘膜隆起剤
CN104902974B (zh) * 2012-07-06 2017-07-28 三维矩阵有限公司 肽溶液的灌装加工法
EP2698162A1 (en) 2012-08-15 2014-02-19 Credentis AG Method for producing a composition for treating a tooth lesion
EP2919826B1 (en) * 2012-11-14 2025-06-11 3-D Matrix Ltd. Vascular embolic system
EP2939602B1 (en) 2012-12-25 2021-04-14 Fuso Pharmaceutical Industries, Ltd. Hemostatic agent applicator
KR20190102101A (ko) * 2013-03-06 2019-09-02 가부시끼가이샤 쓰리디 매트릭스 정제된 양친매성 펩타이드 조성물을 이용하는 수술 방법
EP2968654A1 (en) * 2013-03-14 2016-01-20 3-D Matrix, Ltd Treatment for bile leakage
EP2968693B1 (en) * 2013-03-14 2022-06-01 3-D Matrix, Ltd. Materials for gastrointestinal obstruction prevention
DK2980098T3 (en) 2013-03-30 2019-01-28 Glytech Inc (Sugar chain) -POLYPEPTIDKOMPLEKS
DK3035974T3 (da) 2013-08-22 2020-01-02 Arch Biosurgery Inc Implanterbare net til styring af bevægelsen af fluider
JP6649251B2 (ja) 2013-09-25 2020-02-19 クレデンティス・アクチェンゲゼルシャフトＣｒｅｄｅｎｔｉｓ ＡＧ 歯を白くするためのデンタルケア製品
EP2853256A1 (en) 2013-09-25 2015-04-01 Credentis AG Dental care product for tooth whitening
JP2015142720A (ja) * 2013-12-27 2015-08-06 株式会社メニコン 止血材
BR112016020584A2 (pt) * 2014-03-10 2017-10-03 3 D Matrix Ltd Composições de peptídeo auto-organizável
US10369237B2 (en) 2014-03-10 2019-08-06 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
US20170173105A1 (en) * 2014-03-10 2017-06-22 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary leakage
EP3116523B1 (en) * 2014-03-10 2018-10-17 3-D Matrix, Ltd. Self-assembling peptides as bronchial obstruction agents
JP6545727B2 (ja) * 2014-03-10 2019-07-17 株式会社スリー・ディー・マトリックス 肺大気胞を治療するための自発組織化ペプチド
CA2943734A1 (en) * 2014-03-28 2015-10-01 Otsuka Chemical Co., Ltd. Hemostatic pharmaceutical composition
BR112016029518A2 (pt) * 2014-06-20 2018-06-19 3-D Matrix, Ltd. materiais e métodos para o enchimento de cavidades ósseas
KR20170117603A (ko) * 2015-04-23 2017-10-23 더 팀켄 컴퍼니 베어링 구성요소를 제조하는 방법
EP3391897B1 (en) 2015-12-18 2021-09-08 3-D Matrix Ltd. Hemostatic composition and hemostatic method using hemostatic composition
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
BR112018068939A2 (pt) * 2016-03-18 2019-01-22 3 D Matrix Ltd oclusão de vazamento de fluido cérebro-espinhal
AU2017235871A1 (en) * 2016-03-18 2018-09-27 3-D Matrix, Ltd. Pancreatic fistula occlusion
WO2017158420A1 (en) * 2016-03-18 2017-09-21 3-D Matrix, Ltd. Preventing biological tissue adhesion
EP3248591A1 (en) 2016-05-24 2017-11-29 Credentis AG Method and product for caries treatment
EP3248590A1 (en) 2016-05-24 2017-11-29 Credentis AG Personal dental care product for caries treatment
CN109641076A (zh) * 2016-06-01 2019-04-16 立美基股份有限公司 具有自组装肽水凝胶的止血敷料
EP3463496A1 (en) * 2016-06-01 2019-04-10 3-D Matrix Ltd. Hemostatic powders with self-assembling peptide hydrogels
JP7012950B2 (ja) * 2016-11-17 2022-01-31 地方独立行政法人東京都立産業技術研究センター 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
US12383421B2 (en) 2017-01-05 2025-08-12 Contraline, Inc. Contraceptive devices
EP3723726A1 (en) 2017-12-15 2020-10-21 3-D Matrix, Ltd. Surfactant peptide nanostructures and uses in drug delivery
WO2020008377A2 (en) 2018-07-03 2020-01-09 3-D Matrix, Ltd. Ionic self-assembling peptides
EP3831360A1 (en) 2019-12-04 2021-06-09 Credentis AG Personal dental care product for preventing demineralisation
EP4090350A1 (en) * 2020-01-13 2022-11-23 Arch Biosurgery, Inc. Self-assembling peptide gel formulation and methods of use
US11534528B2 (en) 2020-03-31 2022-12-27 3-D Matrix, Ltd. Sterilization of self-assembling peptides by irradiation
US11154470B1 (en) 2020-07-31 2021-10-26 vVardis AG Anti-inflammatory and senolytic dental care product with tooth whitening characteristics
CN111848736B (zh) * 2020-08-05 2021-12-31 赛克赛斯生物科技股份有限公司 自组装多肽、制备方法、自组装多肽制剂及应用
CN111939323B (zh) * 2020-08-08 2022-06-10 武汉速普生物科技有限公司 含有透明质酸连接肽和连接蛋白末端肽的功能性多肽水凝胶及其应用
EP3957338A1 (en) 2020-08-20 2022-02-23 Aobakasei Kabushiki Kaisha Liquid medical material
JP7740691B2 (ja) * 2021-09-03 2025-09-17 国立大学法人 岡山大学 注入材
US20250082552A1 (en) 2023-09-11 2025-03-13 Credentis Ag Dental Care Products Comprising Stannous Flouride

Family Cites Families (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582640A (en) 1982-03-08 1986-04-15 Collagen Corporation Injectable cross-linked collagen implant material
US4642117A (en) 1985-03-22 1987-02-10 Collagen Corporation Mechanically sheared collagen implant material and method
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
US5236903A (en) 1988-06-24 1993-08-17 Ichiro Azuma Polypeptide comprising repeated cell-adhesive core sequences
US5110604A (en) 1988-06-30 1992-05-05 Collagen Corporation Processes for producing collagen matrixes and methods of using same
US5126141A (en) 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5550187A (en) 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5629291A (en) 1992-01-31 1997-05-13 La Jolla Cancer Research Foundation Methods of modulating fibronectin extracellular matrix assembly
US5292514A (en) 1992-06-24 1994-03-08 Minnesota Mining And Manufacturing Company Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5955343A (en) 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
GB2274988A (en) * 1993-02-10 1994-08-17 Mcconn Stern Rita Iodine containing wound-healing preparations
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5773577A (en) 1994-03-03 1998-06-30 Protein Polymer Technologies Products comprising substrates capable of enzymatic cross-linking
US5527610A (en) 1994-05-20 1996-06-18 The Uab Research Foundation Elastomeric polypeptide matrices for preventing adhesion of biological materials
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
WO1996040033A1 (en) 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
ATE247494T1 (de) 1996-04-04 2003-09-15 Baxter Ag Blutstillender schwamm auf kollagenbasis
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
AU6019898A (en) 1997-01-09 1998-08-03 Cohesion Technologies, Inc. Devices for tissue repair and methods for preparation and use thereof
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US6228324B1 (en) 1997-11-28 2001-05-08 Seikagaku Corporation Sterilizing method for medical sterilization packaging and injection pack
US6187555B1 (en) 1998-04-16 2001-02-13 3M Innovative Properties Company Spores with increased sensitivity to sterilants using additives that bind to sterilant-sensitive sites
JP2002519363A (ja) 1998-07-06 2002-07-02 カヤンデル，イー・オラヴィ ナノバクテリアの根絶法
US6046160A (en) 1999-07-22 2000-04-04 Deroyal Industries, Inc. Composition and method for enhancing wound healing
DE60133271T2 (de) * 2000-05-16 2009-04-23 Genentech, Inc., South San Francisco Behandlung von knorpelerkrankungen
AU2001292609A1 (en) 2000-09-11 2002-03-26 Closure Medical Corporation Bronchial occlusion method and apparatus
AU2002255220B2 (en) 2001-01-25 2007-05-31 Topaz Investment As Carrier with solid fibrinogen and solid thrombin
US7449180B2 (en) 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
ATE419333T1 (de) 2001-02-06 2009-01-15 Massachusetts Inst Technology Peptidgerüstverkapselung von gewebszellen und verwendungen davon
BR0209434A (pt) 2001-05-04 2006-02-07 Scripps Research Inst Peptìdeos antimicrobianos e composições
AU2003222167A1 (en) 2002-04-02 2003-10-20 Northwestern University Peptide amphiphile solutions and self assembled peptide nanofiber networks
WO2003096972A2 (en) 2002-05-13 2003-11-27 Massachusetts Institute Of Technology Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof
GB0216286D0 (en) 2002-07-15 2002-08-21 Univ Leeds Network
WO2004013161A2 (en) 2002-08-06 2004-02-12 Epix Pharmaceuticals, Inc. Peptide aggregates
EP1636250B1 (en) 2003-06-25 2016-01-06 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and uses thereof
US7713923B2 (en) 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
WO2005001079A2 (en) 2003-06-27 2005-01-06 Ethicon, Incorporated Soft tissue repair and regeneration using postpartum-derived cells
US7846891B2 (en) 2003-10-17 2010-12-07 Massachusetts Institute Of Technology Self-assembling peptides for regeneration and repair of neural tissue
GB0404374D0 (en) 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
JP2005263631A (ja) 2004-03-16 2005-09-29 Sanyo Chem Ind Ltd 細胞接着性ポリペプチド
US20050266086A1 (en) 2004-06-01 2005-12-01 Sawhney Amarpreet S Intrauterine applications of materials formed in situ
US20060084607A1 (en) * 2004-07-06 2006-04-20 Lisa Spirio Purified amphiphilic peptide compositions and uses thereof
WO2006016524A1 (ja) 2004-08-11 2006-02-16 Pioneer Corporation 外部制御記録再生システム
CA2592292A1 (en) 2005-01-04 2006-07-13 The Brigham And Women's Hospital, Inc. Sustained delivery of pdgf using self-assembling peptide nanofibers
JP5204646B2 (ja) 2005-04-25 2013-06-05 マサチューセッツ インスティテュート オブ テクノロジー 止血および他の生理学的活性を促進するための組成物および方法
US9162005B2 (en) * 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
CA2618184A1 (en) 2005-06-17 2006-12-28 Baxter International Inc. Stable buffered, pharmaceutical compositions including motilin-like peptides
CN101198350A (zh) 2005-06-17 2008-06-11 巴克斯特国际公司 含胃动素样肽的稳定的缓冲的药物组合物
US20060293243A1 (en) 2005-06-17 2006-12-28 Navneet Puri Stable, buffered, pharmaceutical compositions including motilin-like peptides
JP4982841B2 (ja) 2005-10-12 2012-07-25 国立大学法人名古屋大学 再生医療骨組成物
WO2007059491A2 (en) 2005-11-14 2007-05-24 University Of Delaware Technology Corporation Novel hydrogels and uses thereof
TW200738261A (en) 2005-12-20 2007-10-16 Bristol Myers Squibb Co Stable protein formulations
ES2439641T3 (es) 2005-12-20 2014-01-24 Bristol-Myers Squibb Company Composiciones y procedimientos de producción de una composición
US9095818B2 (en) 2009-06-15 2015-08-04 Biovec Transfusion, Llc Method of filtering platelets to remove antiplatelet and anticoagulant agents
US9084837B2 (en) 2006-04-25 2015-07-21 Massachusetts Institute Of Technology Compositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions
US7875017B2 (en) 2007-04-11 2011-01-25 Henry Ford Health System Cardiac repair, resizing and reshaping using the venous system of the heart
US8022178B2 (en) 2006-09-26 2011-09-20 Massachusetts Institute Of Technology Modified self-assembling peptides
WO2008073392A2 (en) 2006-12-11 2008-06-19 3D Matrix, Inc. Compositions and methods for cardiac tissue protection and regeneration
DK2146733T3 (da) 2007-03-14 2021-01-11 Arch Biosurgery Inc Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
JP2009011341A (ja) 2007-06-29 2009-01-22 Yuka Denshi Co Ltd ペースト状材料充填容器
US20090053103A1 (en) 2007-08-20 2009-02-26 William Patrick Mortimer Non-linting sterilization packaging material
US20110002880A1 (en) 2007-12-05 2011-01-06 3-D Matrix, Ltd. Material For Wound Healing and Skin Reconstruction
US8834926B2 (en) 2008-08-08 2014-09-16 University Of Delaware Macromolecular diffusion and release from self-assembled β-hairpin peptide hydrogels
CN102170919A (zh) 2008-10-06 2011-08-31 三维肽胶株式会社 组织闭塞剂
CN101514225B (zh) 2008-10-13 2011-09-14 西安蓝晶生物科技有限公司 自聚体多肽及其制备方法和应用
EP2757108B1 (en) 2009-03-09 2016-08-31 Menicon Co., Ltd. Self-assembling peptide and peptide gel with high strength
WO2011005381A2 (en) 2009-06-01 2011-01-13 Trustees Of Tufts College Vortex-induced silk fibroin gelation for encapsulation and delivery
US9439941B2 (en) 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
JP5855651B2 (ja) 2010-07-16 2016-02-09 マサチューセッツ インスティテュート オブ テクノロジー 改変を組み込んだ自己組織化ペプチドおよびその使用方法
JP2012082180A (ja) 2010-10-14 2012-04-26 Nagoya Univ 骨再生用自己組織化ペプチドハイドロゲル
ES2653667T3 (es) 2011-09-02 2018-02-08 3-D Matrix, Ltd. Péptidos anfifílicos para la oclusión del escape de aire torácico
WO2013133413A1 (ja) 2012-03-09 2013-09-12 株式会社スリー・ディー・マトリックス 粘膜隆起剤
CN104902974B (zh) 2012-07-06 2017-07-28 三维矩阵有限公司 肽溶液的灌装加工法
PT2877497T (pt) 2012-07-27 2017-02-14 Koninklijke Coöperatie Cosun U A Agente estruturante para detergentes líquidos e produtos de higiene pessoal
EP2919826B1 (en) 2012-11-14 2025-06-11 3-D Matrix Ltd. Vascular embolic system
CN103251690B (zh) 2013-02-26 2015-10-28 中国人民解放军新疆军区联勤部药品仪器检验所 维药瘤果黑种草子挥发油在制备治疗慢性阻塞性肺病药物的应用
KR20190102101A (ko) 2013-03-06 2019-09-02 가부시끼가이샤 쓰리디 매트릭스 정제된 양친매성 펩타이드 조성물을 이용하는 수술 방법
EP2968693B1 (en) 2013-03-14 2022-06-01 3-D Matrix, Ltd. Materials for gastrointestinal obstruction prevention
EP2968654A1 (en) 2013-03-14 2016-01-20 3-D Matrix, Ltd Treatment for bile leakage
DK3035974T3 (da) 2013-08-22 2020-01-02 Arch Biosurgery Inc Implanterbare net til styring af bevægelsen af fluider
WO2015030063A1 (ja) 2013-09-02 2015-03-05 大成化工株式会社 シリンジおよびシリンジセット
JP6545727B2 (ja) 2014-03-10 2019-07-17 株式会社スリー・ディー・マトリックス 肺大気胞を治療するための自発組織化ペプチド
EP3116523B1 (en) 2014-03-10 2018-10-17 3-D Matrix, Ltd. Self-assembling peptides as bronchial obstruction agents
US10369237B2 (en) 2014-03-10 2019-08-06 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
US20170173105A1 (en) 2014-03-10 2017-06-22 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary leakage
BR112016020584A2 (pt) 2014-03-10 2017-10-03 3 D Matrix Ltd Composições de peptídeo auto-organizável
BR112016029518A2 (pt) 2014-06-20 2018-06-19 3-D Matrix, Ltd. materiais e métodos para o enchimento de cavidades ósseas
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions

Also Published As

Publication number Publication date
US10576123B2 (en) 2020-03-03
EP3470093A1 (en) 2019-04-17
JP2015077416A (ja) 2015-04-23
CN102170919A (zh) 2011-08-31
ES2821436T3 (es) 2021-04-26
PH12017501278B1 (en) 2018-03-12
US11801281B2 (en) 2023-10-31
EP2345433A1 (en) 2011-07-20
US10596225B2 (en) 2020-03-24
JP6200997B2 (ja) 2017-09-20
US20140038909A1 (en) 2014-02-06
EP4183425A1 (en) 2023-05-24
EP3238749B2 (en) 2025-06-04
US20240115652A1 (en) 2024-04-11
EP3800197B1 (en) 2022-09-28
RU2011118341A (ru) 2012-11-20
EP3800197A1 (en) 2021-04-07
EP2345433B1 (en) 2017-03-01
EP3238749A1 (en) 2017-11-01
JPWO2010041636A1 (ja) 2012-03-08
JP2018033954A (ja) 2018-03-08
SG194405A1 (en) 2013-11-29
RU2016102347A (ru) 2018-11-20
EP2345433A4 (en) 2013-12-25
EP3800197B8 (en) 2023-03-22
CN105435211A (zh) 2016-03-30
PH12019502295A1 (en) 2021-03-01
HK1223025A1 (zh) 2017-07-21
EP3238749B1 (en) 2018-09-19
KR101670099B1 (ko) 2016-10-27
ES2624484T3 (es) 2017-07-14
WO2010041636A1 (ja) 2010-04-15
JP5922749B2 (ja) 2016-05-24
US20200222496A1 (en) 2020-07-16
JP6492137B2 (ja) 2019-03-27
ES2694000T3 (es) 2018-12-17
EP3470093B1 (en) 2020-08-19
US20110201541A1 (en) 2011-08-18
PH12017501278A1 (en) 2018-03-12
US20220193184A1 (en) 2022-06-23
JP2016174912A (ja) 2016-10-06
PL3470093T3 (pl) 2021-01-25
KR20110083648A (ko) 2011-07-20
BRPI0920030B1 (pt) 2019-03-26

Similar Documents

Publication Publication Date Title
BRPI0920030A2 (pt) agente de oclusão do tecido
BRPI0919884A2 (pt) cateter de perfusão de oclusão
BRPI0924411A2 (pt) "dispositivos de oclusão cardíaca"
EP2296593A4 (en) MEDICAL HEAD COVER
BR112013013311A2 (pt) agente terapêutico de indução de citotoxicidade
BRPI0812209A2 (pt) Partícula de liberação contendo agente de benefício
IT1391555B1 (it) Apparato trattamento extracorporeo sangue
DK2310071T3 (da) Ekkogen medicinsk kanyle
EP2327448A4 (en) defibrillation catheter
BRPI0719594A2 (pt) Partícula de liberação contendo agente de benefício
EP2351511A4 (en) MEDICAL DEVICE OF CAPSULE TYPE
EP2328489A4 (en) DEVICE FOR TISSUE MODIFICATION
BRPI0920314A2 (pt) dispositivo médico com liberação controlada de agente antibacteriano
BRPI0923823A2 (pt) Agente de colaboração.
EP2131749A4 (en) Surgical stapling apparatus
BR112012005247A2 (pt) agente antifitoviral
EP2351595A4 (en) Medical connection
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit
EP2258421A4 (en) MEDICAL INSTRUMENT
BRPI0819257A2 (pt) monitor de pressão sanguínea
BRPI0814895A2 (pt) Preenchedor de tecido fotoiniciado
BRPI0915822A2 (pt) dispositivo médico
IL211073A0 (en) Surgical endoscope
BRPI0716118A2 (pt) agente anti-ruga
DK2237727T3 (da) Vævsretraktor

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/10/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/10/2009, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 12A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.